Eurofins-Cerep SA (ALECR) - Total Assets

Latest as of June 2025: €84.58 Million EUR ≈ $98.88 Million USD

Based on the latest financial reports, Eurofins-Cerep SA (ALECR) holds total assets worth €84.58 Million EUR (≈ $98.88 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Eurofins-Cerep SA for net asset value and shareholders' equity analysis.

Eurofins-Cerep SA - Total Assets Trend (2000–2024)

This chart illustrates how Eurofins-Cerep SA's total assets have evolved over time, based on quarterly financial data.

Eurofins-Cerep SA - Asset Composition Analysis

Current Asset Composition (December 2024)

Eurofins-Cerep SA's total assets of €84.58 Million consist of 86.4% current assets and 13.6% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 20.9%
Accounts Receivable €51.16 Million 60.9%
Inventory €3.36 Million 4.0%
Property, Plant & Equipment €8.66 Million 10.3%
Intangible Assets €202.30K 0.2%
Goodwill €2.23 Million 2.7%

Asset Composition Trend (2000–2024)

This chart illustrates how Eurofins-Cerep SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Eurofins-Cerep SA market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Eurofins-Cerep SA's current assets represent 86.4% of total assets in 2024, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 20.9% of total assets in 2024, up from 8.1% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2000.
  • Asset Diversification: The largest asset category is accounts receivable at 60.9% of total assets.

Eurofins-Cerep SA Competitors by Total Assets

Key competitors of Eurofins-Cerep SA based on total assets are shown below.

Company Country Total Assets
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Inoviq Ltd
AU:IIQ
Australia AU$24.52 Million
Bcal Diagnostics Ltd
AU:BDX
Australia AU$7.17 Million
Imagion Biosystems Ltd
AU:IBX
Australia AU$932.48K
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Monash Ivf Group Ltd
AU:MVF
Australia AU$510.21 Million
Cryosite Ltd
AU:CTE
Australia AU$19.46 Million

Eurofins-Cerep SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 8.34 7.64 4.58
Quick Ratio 7.97 7.18 4.32
Cash Ratio 0.00 0.00 0.00
Working Capital €65.03 Million €57.72 Million €27.25 Million

Eurofins-Cerep SA - Advanced Valuation Insights

This section examines the relationship between Eurofins-Cerep SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.06
Latest Market Cap to Assets Ratio 0.95
Asset Growth Rate (YoY) 6.1%
Total Assets €84.06 Million
Market Capitalization $79.70 Million USD

Valuation Analysis

Near Book Valuation: The market values Eurofins-Cerep SA's assets close to their book value (0.95x), suggesting investors view the company's assets at approximately fair value.

Positive Asset Growth: Eurofins-Cerep SA's assets grew by 6.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Eurofins-Cerep SA (2000–2024)

The table below shows the annual total assets of Eurofins-Cerep SA from 2000 to 2024.

Year Total Assets Change
2024-12-31 €84.06 Million
≈ $98.28 Million
+6.07%
2023-12-31 €79.25 Million
≈ $92.65 Million
+11.54%
2022-12-31 €71.05 Million
≈ $83.06 Million
+18.95%
2021-12-31 €59.73 Million
≈ $69.83 Million
+29.67%
2020-12-31 €46.06 Million
≈ $53.85 Million
+15.30%
2019-12-31 €39.95 Million
≈ $46.71 Million
+13.31%
2018-12-31 €35.26 Million
≈ $41.22 Million
+16.83%
2017-12-31 €30.18 Million
≈ $35.28 Million
+16.33%
2016-12-31 €25.94 Million
≈ $30.33 Million
+3.02%
2015-12-31 €25.18 Million
≈ $29.44 Million
+9.97%
2014-12-31 €22.90 Million
≈ $26.77 Million
-17.89%
2013-12-31 €27.89 Million
≈ $32.60 Million
-7.92%
2012-12-31 €30.28 Million
≈ $35.40 Million
-7.45%
2011-12-31 €32.72 Million
≈ $38.26 Million
-8.84%
2010-12-31 €35.90 Million
≈ $41.97 Million
-18.98%
2009-12-31 €44.31 Million
≈ $51.80 Million
-19.30%
2008-12-31 €54.91 Million
≈ $64.19 Million
-12.47%
2007-12-31 €62.73 Million
≈ $73.34 Million
-17.86%
2006-12-31 €76.37 Million
≈ $89.29 Million
-8.70%
2005-12-31 €83.65 Million
≈ $97.79 Million
+30.95%
2004-12-31 €63.87 Million
≈ $74.68 Million
+24.65%
2003-12-31 €51.24 Million
≈ $59.91 Million
+7.39%
2002-12-31 €47.72 Million
≈ $55.78 Million
+16.67%
2001-12-31 €40.90 Million
≈ $47.81 Million
+72.80%
2000-12-31 €23.67 Million
≈ $27.67 Million
--

About Eurofins-Cerep SA

PA:ALECR France Diagnostics & Research
Market Cap
$93.76 Million
€80.20 Million EUR
Market Cap Rank
#20060 Global
#312 in France
Share Price
€15900.00
Change (1 day)
+0.63%
52-Week Range
€15400.00 - €18600.00
All Time High
€18600.00
About

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and… Read more